{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:46:47Z","timestamp":1744181207872,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI 129844"],"award-info":[{"award-number":["R21 AI 129844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010470","name":"Gillson Longenbaugh Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13073-018-0561-2","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T08:03:41Z","timestamp":1530000221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Developing Zika vaccines: the lessons for disease X"],"prefix":"10.1186","volume":"10","author":[{"given":"Alan D. T.","family":"Barrett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"561_CR1","unstructured":"World Health Organization. A research and development blueprint for action to prevent epidemics. 2018. \n                    http:\/\/www.who.int\/blueprint\/en\/\n                    \n                  . Accessed 26 May 2018."},{"key":"561_CR2","unstructured":"World Health Organization. List of blueprint priority diseases. 2018. \n                    http:\/\/www.who.int\/blueprint\/priority-diseases\/en\/\n                    \n                  . Accessed 26 May 2018."},{"key":"561_CR3","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1038\/npjvaccines.2016.7","volume":"1","author":"BR Dawes","year":"2016","unstructured":"Dawes BR, Smalley CA, Tiner BL, Beasley DWC, Milligan GN, Reece LM, et al. Research and development of Zika virus vaccines. NPJ Vaccines. 2016;1:16007. \n                    https:\/\/doi.org\/10.1038\/npjvaccines.2016.07\n                    \n                  .","journal-title":"NPJ Vaccines."},{"key":"561_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aam7120","volume":"358","author":"L Yuan","year":"2017","unstructured":"Yuan L, Huang XY, Liu ZY, Zhang F, Zhu XL, Yu JY, et al. A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science. 2017;358:933\u20136.","journal-title":"Science"},{"key":"561_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"C Shan","year":"2017","unstructured":"Shan C, Muruato AE, Nunes BTD, Luo H, Xie X, Medeiros DBA, et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med. 2017;23:763\u20137.","journal-title":"Nat Med"},{"key":"561_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","volume":"391","author":"K Modjarrad","year":"2018","unstructured":"Modjarrad K, Lin L, George SL, Stephenson KE, Eckels KH, De La Barrera RA, et al. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials. Lancet. 2018;391:563\u201371.","journal-title":"Lancet"},{"key":"561_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","volume":"391","author":"MR Gaudinski","year":"2018","unstructured":"Gaudinski MR, Houser KV, Morabito KM, Hu Z, Yamshchikov G, Rothwell RS, et al. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet. 2018;391:552\u201362.","journal-title":"Lancet"},{"key":"561_CR8","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","volume":"1","author":"K Muthumani","year":"2016","unstructured":"Muthumani K, Griffin BD, Agarwal S, Kudchodkar SB, Reuschel EL, Choi H, et al. In vivo protection against ZIKV infection and pathogenesis through passive antibody. NPJ Vaccines. 2016;1:16021.","journal-title":"NPJ Vaccines"},{"key":"561_CR9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, et al. Modified mRNA vaccines protect against Zika virus infection. Cell. 2017;168:1114\u201325.","journal-title":"Cell"},{"key":"561_CR10","doi-asserted-by":"publisher","unstructured":"Frantz PN, Teeravechyan S, Tangy F. Measles-derived vaccines to prevent emerging viral diseases. Microbes Infect. 2018; \n                    https:\/\/doi.org\/10.1016\/j.micinf.2018.01.005\n                    \n                  .","DOI":"10.1016\/j.micinf.2018.01.005"},{"key":"561_CR11","doi-asserted-by":"publisher","unstructured":"Abbink P, Larocca RA, Visitsunthorn K, Boyd M, De La Barrera RA, Gromowski GD, et al. Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Sci Transl Med. 2017;9 \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aao4163\n                    \n                  .","DOI":"10.1126\/scitranslmed.aao4163"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-018-0561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13073-018-0561-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-018-0561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:06:48Z","timestamp":1589548008000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-018-0561-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1186\/s13073-018-0561-2","relation":{},"ISSN":["1756-994X"],"issn-type":[{"type":"electronic","value":"1756-994X"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"26 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not relevant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"ADTB declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"47"}}